Fluvoxamine-induced neuroleptic malignant syndrome
Neuroleptic malignant syndrome (NMS) is an uncommon but life-threatening idiosyncratic drug reaction that occurs following neuroleptic drug exposure. The estimated incidence of NMS is though very low, resulting mortality rates range between 4% and 30%. There is increasing evidence that “Atypical” an...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Col·lecció: | Journal of the Scientific Society |
| Matèries: | |
| Accés en línia: | http://www.jscisociety.com/article.asp?issn=0974-5009;year=2017;volume=44;issue=3;spage=161;epage=162;aulast=Bellad |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|